Outcome of Immunization of Cynomolgus Monkeys with Recombinant Semliki Forest Virus Encoding Human Immunodeficiency Virus Type 1 Envelope Protein and Challenge with a High Dose of SHIV-4 Virus-Reference-Cited by-同舟云学术

Outcome of Immunization of Cynomolgus Monkeys with Recombinant Semliki Forest Virus Encoding Human Immunodeficiency Virus Type 1 Envelope Protein and Challenge with a High Dose of SHIV-4 Virus

Published:1997-11-20 Issue:17 Volume:13 Page:1487-1495
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

BERGLUND PETER,QUESADA-ROLANDER MARLENE,PUTKONEN PER,BIBERFELD GUNNEL,THORSTENSSON RIGMOR,LILJESTRÖM PETER

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.1997.13.1487

Reference63 articles.

1. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

2. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160

3. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells

4. Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction Studies of Hexameric and Pentameric IgMs with Serum-Derived C1q and Recombinant C1q Mimetics;Life;2024-05-17

2. Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses;Vaccines;2023-06-24

3. mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV;Frontiers in Immunology;2023-04-24

4. Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the Coronaviridae and Togaviridae families (Review);Experimental and Therapeutic Medicine;2022-11-30

5. Recent advances and strategies in vaccine development against HPV;Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies;2022